High materiality7/10
Cytokinetics price target raised to $113 from $112 at RBC Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RBC Capital raises Cytokinetics target to $113 from $112; current price $60.21.
- Target $113 (from $112); price $60.21; RBC Capital
Key facts
- 01
Target: $113
- 02
Posted price: $60.21
- 03
Analyst firm: RBC Capital
- 04
Analyst: Leonid Timashev
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.